AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says
AstraZeneca's Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday.The findings from the new Phase 3 trial, which included more than 32,000 participants,…